Omalizumab in Children

Omalizumab is a recombinant humanized monoclonal antibody that reduces levels of circulating immunoglobulin E (IgE) and expression of IgE high-affinity receptors on mast cells and basophils, interrupting the subsequent allergic inflammatory cascade. Current indications for treatment with omalizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Licari, Amelia, Marseglia, Alessia, Caimmi, Silvia, Castagnoli, Riccardo, Foiadelli, Thomas, Barberi, Salvatore, Marseglia, Gian Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250568/
https://www.ncbi.nlm.nih.gov/pubmed/25404353
http://dx.doi.org/10.1007/s40272-014-0107-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250568/
https://www.ncbi.nlm.nih.gov/pubmed/25404353
http://dx.doi.org/10.1007/s40272-014-0107-z

Ejemplares similares